Overview
Balance Sheet
Cash Flow
Growth Analysis
2024
2023
2022
2021
2020
Profitability Metrics
Gross Margin
75.50%
Operating Margin
14.38%
Net Margin
11.87%
Efficiency Metrics
Revenue per Expense Ratio
1.21
R&D as % of Revenue
14.07%
Earnings Quality
EBITDA Margin
26.45%
Income Tax Rate
16.44%
EPS
4.2500000000
Balance Sheet Analysis
Current Ratio
1.09
Cash Ratio
0.53
Working Capital
$2.44B
Debt to Equity
0.23
Debt to Assets
13.59%
Equity Ratio
59.75%
Cash Flow Analysis
Operating Cash Flow Ratio
29.36%
Free Cash Flow Ratio
27.25%
CapEx to Revenue
2.11%
Dividends Paid
No dividends paid
Stock Buybacks
$7.62B
Total Shareholder Returns
$7.62B
Cash Position Change
38.84%
Key Takeaways (2024 FY)
Maintained positive net income growth despite revenue changes
Detailed Growth Metrics
Core Performance
Revenue
11.18%
Net Income
1,888.46%
EPS
1,923.81%
Operating Income
386.50%
Operational Efficiency
R&D Expenses
-2.95%
SG&A Expenses
-4.15%
Operating Cash Flow
43.92%
Free Cash Flow
50.45%
Balance Sheet Health
Assets
0.99%
Debt
-3.73%
Book Value per Share
4.09%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
0.00%
Shares Outstanding
-1.81%
Long Term Trends
3Y Revenue/Share
52.90%
5Y Revenue/Share
102.35%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%